For the quarter ending 2025-09-30, IDXG has $12,036K in assets. $12,334K in debts. $1,423K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,423 | 502 | ||
| Accounts receivable | 5,966 | 7,231 | ||
| Other current assets | 1,741 | 1,771 | ||
| Total current assets | 9,130 | 9,504 | ||
| Property and equipment, net | 1,541 | 1,366 | ||
| Operating lease right of use assets | 1,320 | 1,420 | ||
| Other long-term assets | 45 | 45 | ||
| Total assets | 12,036 | 12,335 | ||
| Accounts payable | 1,411 | 1,250 | ||
| Accrued salary and bonus | 1,447 | 2,045 | ||
| Other accrued expenses | 1,450 | 1,422 | ||
| Note payable at fair value | 977 | 1,772 | ||
| Current liabilities of discontinued operations | 660 | 660 | ||
| Total current liabilities | 5,945 | 7,149 | ||
| Operating lease liabilities, net of current portion | 864 | 974 | ||
| Other long-term liabilities | 5,525 | 5,425 | ||
| Redeemable preferred stock, .01 par value 5,000,000 shares authorized, 47,000 shares series c issued and outstanding | - | 0 | ||
| Total liabilities | 12,334 | 13,548 | ||
| Common stock, .01 par value 100,000,000 shares authorized 4,569,333 and 4,539,663 shares issued, respectively 4,428,539 and 4,409,323 shares outstanding, respectively | 407 | 407 | ||
| Additional paid-in capital | 234,829 | 234,822 | ||
| Accumulated deficit | -233,462 | -234,373 | ||
| Treasury stock, at cost (140,794 and 130,340 shares, respectively) | 2,072 | 2,069 | ||
| Total stockholders deficit | -298 | -1,213 | ||
| Total liabilities and stockholders deficit | 12,036 | 12,335 | ||
INTERPACE BIOSCIENCES, INC. (IDXG)
INTERPACE BIOSCIENCES, INC. (IDXG)